Lactose

Overview

A disaccharide of glucose and galactose in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.

Indication

Not Available

Associated Conditions

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Hypothyroidism
Opioid Dependence
Thyroid Cancer

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Amantadine for COVID-19	2021/05/20	NCT04894617	Phase 3	UNKNOWN	Copenhagen University Hospital, Hvidovre
Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery	2021/03/10	NCT04791943	Phase 2	Recruiting	Montefiore Medical Center
A Comparison of Two Different Single Doses of Prednisolone on Endodontic Inter-appointment Pain	2020/07/22	NCT04481971	Phase 2	UNKNOWN	King Saud University
Human Cerebral Blood Flow Regulation	2020/02/11	NCT04265053	Early Phase 1	Recruiting	University of Wisconsin, Madison
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel	2020/01/22	NCT04237090	Phase 3	Completed	Ciusss de L'Est de l'Île de Montréal
Investigation of Nicotine Seeking Behavior in Current Smokers	2018/09/13	NCT03670212	Phase 1	Completed	Wayne State University
PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2	2018/07/10	NCT03582176	Phase 3	Completed	University of Calgary
Preventing Recurrent Urinary Tract Infections With α-D-mannose	2018/04/13	NCT03497598	Phase 4	Terminated	Kantonsspital Aarau
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients with Cocaine Addiction	2018/02/06	NCT03423667	Phase 2	Terminated	Salvatore Campanella
Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema	2017/05/22	NCT03161652	Phase 2	Recruiting	Carmen Clapp

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
Nutura Infant Formulated Supplement 2	219865	Functional Foods Global Pty Ltd	Medicine	A	2/4/2014
Nuora Infant Formulated Supplement 2	219746	Functional Foods Global Pty Ltd	Medicine	A	1/30/2014
Nutura Toddler Formulated Supplement 3	219866	Functional Foods Global Pty Ltd	Medicine	A	2/4/2014
Nuora Toddler Formulated Supplement 3	219747	Functional Foods Global Pty Ltd	Medicine	A	1/30/2014
Nutura Infant Formulated Supplement 1	219864	Functional Foods Global Pty Ltd	Medicine	A	2/4/2014
Nuora Infant Formulated Supplement 1	219745	Functional Foods Global Pty Ltd	Medicine	A	1/30/2014

Related News

3P Innovation Launches Next-Generation DPI Filling Technology, Promising Faster Production of Inhalable Therapeutics

2 months ago

3P Innovation has introduced a next-generation dry powder inhaler (DPI) filling technology that processes powders up to five times faster than current market alternatives, following the expiration of GSK's Diskus DPI patent in April 2022.

Help Us Improve

Your feedback helps us provide better drug information and insights.

AI-Powered Research

Premium Access